Rivipansel

GlycoMimetics shares crash after Pfizer team dismisses their lead drug as a PhIII failure
Endpoints
Mon, 08/5/19 - 12:03 am
Pfizer
GlycoMimetics
sickle cell disease
Rivipansel
This could be the next $1 billion drug, if patients get on board
Yahoo/Marketwatch
Tue, 02/27/18 - 09:55 am
sickle cell disease
Rivipansel
Pfizer
clinical trials
Drug Makers Take Page From Hollywood to Spread the Risk
FOX Business
Sun, 04/30/17 - 12:45 pm
Pfizer
Rivipansel
sickle cell disease
clinical trials